GUGGENHEIM CAPITAL LLC - IMMUNOMEDICS INC ownership

IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 1 filers reported holding IMMUNOMEDICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GUGGENHEIM CAPITAL LLC ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q3 2020$7,345,000
+47.3%
86,381
-38.6%
0.05%
+35.9%
Q2 2020$4,985,000
+149.7%
140,643
-5.0%
0.04%
+95.0%
Q1 2020$1,996,000
-46.8%
148,082
-16.5%
0.02%
-28.6%
Q4 2019$3,751,000
+87.5%
177,270
+17.5%
0.03%
+75.0%
Q3 2019$2,001,000
-23.6%
150,893
-20.1%
0.02%
-23.8%
Q2 2019$2,620,000
-23.6%
188,914
+5.8%
0.02%
-25.0%
Q1 2019$3,430,000
+42.3%
178,578
+5.7%
0.03%
+40.0%
Q4 2018$2,410,000
-33.5%
168,894
-2.9%
0.02%
-16.7%
Q3 2018$3,622,000
-7.5%
173,893
+5.2%
0.02%
-7.7%
Q2 2018$3,914,000
+44.5%
165,362
-10.8%
0.03%
+271.4%
Q1 2018$2,709,000
-18.4%
185,415
-9.7%
0.01%
-12.5%
Q4 2017$3,320,000205,3800.01%
Other shareholders

There were no reported owners of IMMUNOMEDICS INC in Q4 2020.

NameSharesValueWeighting ↓
View complete list of IMMUNOMEDICS INC shareholders